Practice Perfect 911
The Pod Periop Medical Management Series #5: Diabetic Medications – Keeping It Sweet So You Don’t Go Sour

Welcome back to our continued series on perioperative medication management for the podiatrist. Today, we’re going to talk about medications related to diabetes. This field of medicine has been changing quite a bit recently, so an update is in order.

Let’s start with a quick discussion about safe glucose levels for elective surgery, and then we’ll do a high-yield review of the medications themselves.

What’s a safe blood sugar level when doing elective surgery?
The easy answer is “the lower the better.” So, a glycosylated hemoglobin as close to normal is best. However, just being diabetic does not preclude a patient from having elective surgery (especially if that elective surgery is meant to decrease the risk of or treat ulcers). The available research has looked primarily at wound healing and skin and skin structure infections (SSI). A full discussion of this is outside the scope of this editorial, but highlighting a couple of representative studies show that, as the hemoglobin A1c rises, especially above 7.5-8%, the risk of infection increasingly rises. Domek, et al found a 5% increase in complication rates with each 1% increase in A1c.1 Similarly, Jupiter, et al reported an increased risk of SSI above 7.3%.2 As a result of these and other research, I use a glycosylated hemoglobin of 8% as a hard cut off for most surgery on diabetics, with a preference of no higher than 7% when possible.

I use a glycosylated hemoglobin (A1c) of 8% as a hard cut off for most surgery on diabetics, with a preference of no higher than 7% when possible.

Diabetic Medication Management in the Perioperative Period
Information below is abstracted from Preiser, et al3 unless indicated otherwise. Additionally, don’t forget that patients with diabetes are at increased risk of cardiovascular complications, so refer to Practice Perfect 910 for a discussion about medications in this class.

Class Class Examples Comments
Sulfonylureas Glimepiride (Amaryl®),
Glipizide (Glucotrol®),
Glyburide (Micronase®)
Hold day of surgery.
 
Calls to stop using Glyburide.
Meglitinides Repaglinide (Prandin®),
Neteglinide (Starlix®)
Hold day of surgery.
Biguanides Metformin (Glucophage®) Hold day of surgery.
Thiazolidinediones Pioglitazone (Actos®) Continue perioperatively.
Alpha-glucosidase inhibitors Acarbose (Precose®) Hold whenever fasting.
Dipeptidyl peptidase-4
inhibitors (DPP-4 Inhibitors)
Sitagliptin (Januvia®)
Linagliptin (Tradjenda®)
Continue perioperatively.
Sodium glucose cotransporter 2 inhibitors
(SGLT2 inhibitors)
Empagliflozin (Jiardiance®) Stop 3 days before surgery.
Glucagon-like peptide-1 agonist (GLP-1 agonist) Semaglutide (Ozempic®) Hold 1-week preop due to decreased gastric emptying.4,5
Long-acting Insulins Levemir®, Lantus®, NPH ½ regular dose on AM of surgery.

*Note: Brand names included due to common use to allow recognition rather than as advertisement.


Link In to PRESENT e-Learning Systems
Join Us on Facebook
Subscribe to our YouTube channel

Desert Foot East 2024

To make a final comment, recent research has shown that patients taking GLP-1 agonists are at an increased risk of perioperative aspiration due to slowed gastric emptying with these medications.4 There’s been some controversy, as the quality of evidence is not high, so some organizations still recommend regular fasting guidelines. Given this controversy, it is safe to hold this medication at least a week in advance but to consult with the patient’s medical doctor if there are questions. Clearly, the management of patients with diabetes is not a simple endeavor.

Best wishes.

Jarrod Shapiro, DPM
PRESENT Practice Perfect Editor
[email protected]

References
  1. Domek N, Dux K, Pinzur M, Weaver F, Rogers T. Association Between Hemoglobin A1c and Surgical Morbidity in Elective Foot and Ankle Surgery. J Foot Ankle Surg. 2016;55(5):939-943.
    Follow this link
  2. Jupiter DC, Humphers JM, Shibuya N. Trends in postoperative infection rates and their relationship to glycosylated hemoglobin levels in diabetic patients undergoing foot and ankle surgery. J Foot Ankle Surg. 2014;53(3):307-311.
    Follow this link
  3. Preiser JC, Provenzano B, Mongkolpun W, Halenarova K, Cnop M. Perioperative Management of Oral Glucose-lowering Drugs in the Patient with Type 2 Diabetes. Anesthesiology. 2020;133(2):430-438.
    Follow this link
  4. Galway U, Chahar P, Schmidt MT, et al. Perioperative challenges in management of diabetic patients undergoing non-cardiac surgery. World J Diabetes. 2021;12(8):1255-1266.
    Follow this link
  5. Joshi G, Abdelmalak BB, Weigel WA, et al. American Society of Anesthesiologists Consensus-Based Guidance on Preoperative Management of Patients (Adults and Children) on Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists. https://www.asahq.org/about-asa/newsroom/news-releases/2023/06/american-society-of-anesthesiologists-consensus-based-guidance-on-preoperative. Last accessed April 24, 2024.
    Follow this link

Major Sponsor